5 October
6 October
5 October
|
EBMT & TPHD Joint Session |
Chairs: Akif Yeşilipek, Selim Çorbacıoğlu | |
| 11.00 – 11.30 | CART in ALL | Adriana Balduzzi(Virtual) |
| 11.30 – 12.00 | CMV Infection in Pediatric Hematopoietic Stem Cell Transplantation | Elif İnce |
| 12.00 – 12.30 | Haploidentical HSCT in Haemoglobinopathies | Selim Çorbacıoğlu |
6 October
|
HALLS |
PEDIATRIC HEMATOLOGY PROGRAM |
|||
|
07.20 - 08.10 |
ORAL PRESENTATION SESSION 2 |
|||
|
07:20 - 07.30 |
Comparison of the quality of life of patients with a beta-thalassemia major, regularly receiving parenteral and oral chelators |
Samira Hasanova |
|
|
|
07.30 - 07.40 |
MRD in Blastıc Plasmacytoıd Dendritic Cell Neoplasm |
Aleksandra Palladina |
|
|
|
07.40 - 07.50 |
The Effect of The Covıd-19 Pandemıc Process on Treatment Compliance in Hemophilia Patients |
Şifa Şahin |
|
|
|
07.50 - 08.00 |
The Mental Health Status of Inpatients with Newly Diagnosed Hematological Cancer During The Covid-19 Pandemic |
Ferda Can(Virtual) |
||
|
08.00 - 08.10 |
Ghosal hematodiaphyseal dysplasia (GHDD) diagnosis and treatment: case report |
Gular Mammadova(Virtual) |
||
|
08.15 - 08.25 |
OPENING REMARKS FOR PEDIATRIC HEMATOLOGY & ONCOLOGY PROGRAMS |
Nurdan Taçyıldız - Özcan Bör |
||
|
|
SESSION 1 - THALASSEMIA |
CHAIR: Bülent Antmen |
||
|
08:25 - 08.55 |
Contemporary Understanding and Management of NTDT |
Ali Taher |
||
|
08.55 - 09.25 |
Thalesemia IntermediateContemporary Understanding and Management of TDT |
Vip Viprakasit(Virtual) |
||
|
09.25 - 09.55 |
Treatment of Sickle Cell Anemia |
Salam Al Kindi |
||
|
09.55 - 10.00 |
General Discussion Chair: Hatice İlgen Şaşmaz |
|||
|
10.00 - 10.30 |
COFFEE BREAK |
|||
|
|
SESSION 2 - THE CHALLENGING LABORATORY ABNORMALITIES |
CHAIRS: Namık Özbek, Ayşegül Ünüvar |
||
|
10.30 - 11.00 |
Neutropenia |
Deniz Karapınar |
||
|
11.00 - 11.30 |
Thrombocytosis |
Burcu Belen Apak |
||
|
11.30 - 12.00 |
Hypereosinophlia |
Gül Nihal Özdemir |
||
|
12.00 - 12.05 |
General Discussion Chair: Tiraje Celkan |
|||
|
12.05 - 12.35 |
BREAK |
|||
|
12.35 - 13.35 |
LUNCH BREAK |
|||
|
|
SESSION 3 - PEDIATRIC LEUKEMIAS |
CHAIRS: Neşe Yaralı, Ali Fettah |
||
|
13.35 - 14.05 |
New Developments in Infant Leukemia |
Francesco Saglio |
||
|
14.05 - 14.35 |
Early T-cell Precursor Acute Lymphoblastic Leukemia |
Hale Ören |
||
|
14.35 - 15.05 |
New Era in the Treatment of B-cell Precursor Leukemia |
Özlem Tüfekçi |
||
|
15.05 - 15.10 |
General Discussion Chair: Hale Ören |
|||
|
15.10 - 15.40 |
BREAK |
|||
|
|
SESSION 4 - HEMOLYTIC ANEMIAS IN PEDIATRIC AGE |
CHAIRS: Serap Karaman - Meryem Albayrak |
||
|
15.40 - 16.10 |
Congenital Hemolytic Anemias |
Achilles Ioalscon(Virtual) |
||
|
16.10 - 16.40 |
Fifteen-minute consultation: Recognition of sickle cell crises in the paediatric emergency department |
İbrahim Eker |
||
|
16.40 - 17.10 |
The other side of Pyruvate Kinase: Lack of activity |
Tekin Aksu |
||
|
17.10 - 17.15 |
General Discussion Chair: Zühre Kaya |
|||
|
17.15- 17.45 |
COFFEE BREAK |
|||
|
|
SESSION 5 - HEMOPHILIA |
CHAIRS: Kaan Kavaklı - Canan Albayrak |
||
|
17.45 - 18.15 |
Subcutanous Treatments Modalities in Hemophilia Care |
Peter Noun |
||
|
18.15 - 18.45 |
New Insights in Gene Treatment |
Alphan Küpesiz |
||
|
18.45 - 19.15 |
Prophylaxis with Extended Half Life Factors |
Can Balkan |
||
|
19.15 - 19.20 |
General Discussion Chair: Bülent Zülfikar |
|||